Taiyen Biotech reports Sep revenue NT$273.0 million
Taiyen Biotech Co. Ltd. reported Sep revenue of NT$273,039,000 versus NT$265,400,000 in 2025. Jan–Sep revenue was NT$2,383,558,000 versus NT$2,491,208,000 in 2025.
Taiyen Biotech Co. Ltd. reported revenue of NT$273,039,000 for 2026, compared with NT$265,400,000 in 2025. For Jan-Sep, revenue totaled NT$2,383,558,000 in 2026 versus NT$2,491,208,000 a year earlier.
Figures are in New Taiwan dollars. Source: Taiwan Stock Exchange.